VLA 0.00% $1.75 viralytics limited

Ann: Ceasing to be a substantial holder from MS, page-47

  1. 891 Posts.
    lightbulb Created with Sketch. 117
    100% agree, personally, I think hell is more likely to freeze over twice before Merck (MSD) and BMS 'collaborate' for the betterment of patient outcomes, big-pharma have always been, and probably always will be, insatiably cash-hungry, money-dogs...

    Bring on 9-12 April (and/or the next round of results, particularly for BMS)...

    Cautiously optimistic...

    ML
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.